50-112-2620

Placental Alkaline Phosphatase Monoclonal Antibody (8B6), Biotin, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-112-2620-Each-of-1 In Stock ₹ 35,600.00

50-112-2620 - Each of 1

₹ 35,600.00

In Stock

Quantity

1

Base Price: ₹ 35,600.00

GST (18%): ₹ 6,408.00

Total Price: ₹ 42,008.00

Antigen

Placental Alkaline Phosphatase

Classification

Monoclonal

Concentration

0.5 mg/mL

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Accession No.

P05187

Gene Symbols

ALPP

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

250

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

ELISA, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)

Clone

8B6

Conjugate

Biotin

Gene

ALPP

Gene Alias

Alkaline phosphatase placental type; Alkaline phosphatase Regan isozyme; alkaline phosphatase, placental; alkaline phosphatase, placental type; alkaline phosphomonoesterase; ALP; Alp1; ALPP; AP-TNAP; DOA1; FLJ11281; FLJ40094; FLJ61142; FLJ93059; Germ-cell alkaline phosphatase; glycerophosphatase; HOPS; MGC161443; MGC167935; nagao Isozyme; P PLAP; PALP; PLA2P; PLAA; placental alkaline phosphatase 1; placental heat-stable alkaline phosphatase; PLAP; PLAP1; PLAP-1; rCG23846-like; Regan isozyme; TNAP; TNSALP

Host Species

Mouse

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2a κ

Related Products

Img

Invitrogen

39-100-0

--

Img

Invitrogen

50-112-4272

--

Img

Invitrogen

44-116-0G

--

Img

Invitrogen

41-989-782

--

Img

Invitrogen

50-112-3661

--

Img

Invitrogen

37-710-0

--

Img

Invitrogen

41-984-380

--

Img

Invitrogen

50-112-2836

--

Description

  • Description: The monoclonal antibody 8B6 recognizes human Placental Alkaline Phosphatase (PLAP), a 130 (or 130 with 65 kDa) enzyme expressed by placental syncytiotrophoblastoid cells
  • This enzyme has slightly different enzyme kinetics from other phosphatases
  • PLAP can be found anchored to the plasma membrane in addition to the cytoplasm
  • Expression is found in several germ line cancers; ovarian and testicular
  • Expression is also present in human embryonic stem cells and bone marrow-derived mesenchymal stromal cells
  • This 8B6 antibody reacts with both the Regan and Nagao isozymes
  • Applications Reported: This 8B6 antibody has been reported for use in immunohistochemical staining of frozen (IHC-F) and formalin-fixed paraffin embedded (IHC-P) tissue, and ELISA
  • Applications Tested: This 8B6 antibody has been tested by immunohistochemistry on formalin-fixed paraffin embedded (FFPE) human placenta with trypsin digestion
  • This antibody can be used at less than or equal to 20 μg/mL
  • It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest
  • Filtration: 0.2 μm post-manufacturing filtered
  • Placental Alkaline Phosphatase plays an important role in the regulation of specific inflammatory disease processes
  • There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney for this form of alkaline phosphatase have been well characterized
  • Placental Alkaline Phosphatase reacts with a membrane-bound isoenzyme (Regan and Nagao type) of Placental Alkaline Phosphatase (PLAP) occurring in the placenta during the 3rd trimester of gestation
  • Placental Alkaline Phosphatase is useful in the identification of testicular germ cell tumors
  • Unlike germ cell tumors, PLAP-positive somatic cell tumors uniformly express epithelial membrane antigen (EMA)
  • A proposed function of Placental Alkaline Phosphatase is matrix mineralization; however, mice that lack a functional form of this enzyme show normal skeletal development
  • Placental Alkaline Phosphatase has been linked directly to hypophosphatasia, a disorder that is characterized by hypercalcemia and includes skeletal defects
  • The character of hypophosphatasia can vary, however, depending on the specific mutation since this determines age of onset and severity of symptoms.